Stergios Bobotis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stergios Bobotis has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Matyas Fehervari
Department of Bariatric Surgery, Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, United Kingdom
2 shared publications - Bibek Das
Department of Surgery and Cancer, Imperial College London, London, UK
1 shared publication - Chetan Parmar
Whittington Hospital, London, UK
1 shared publication E. McGlone
Department of Upper GI Academic Surgery, The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, United Kingdom; Department of Bariatric Surgery, Maidstone and Tunbridge Wells NHS Trust, United Kingdom
1 shared publication- Elisavet Arsenaki
Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, UK
1 shared publication - Emma Rose McGlone
Department of Surgery and Cancer, Imperial College London, London, UK
1 shared publication
Latest Publications
- Open Access
- 7 November 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
Pancreatic exocrine function following bariatric surgery: a systematic review and meta-analysis
- 7 November 2026
- Published by Elsevier in Surgery for Obesity and Related Diseases
Open AccessPancreatic exocrine function following bariatric surgery: a systematic review and meta-analysis
- Open Access
- 22 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5027-5036
The Impact of Hospital Volume on Bariatric Surgery Safety: A Population-Based Study using Data from the National Bariatric Surgery Registry of the United Kingdom
Background: Hospital procedural volume is recognised as an important determinant of outcomes in complex surgery. However, the volume–outcome relationship in bariatric surgery remains incompletely defined. This study examined the association between hospital procedural volume and major complications in primary metabolic bariatric surgery using the United Kingdom (UK) National Bariatric Surgery Registry (NBSR). Methods: Prospectively collected NBSR data from 2014 to 2023 were analysed. Adults undergoing RYGB, SG, or OAGB were included. Hospitals were stratified into quartiles using a four-year moving average of annual procedural volume. Primary outcomes were major postoperative complications, including gastrojejunal obstruction, bleeding, and Clavien-Dindo grade ≥ III events. Multivariable logistic regression assessed associations between hospital volume and outcomes. Results: A total of 54,195 patients were included (RYGB: 23,139; SG: 25,300; OAGB: 4,744). Complication rates were low overall. For RYGB, obstruction rates declined with increasing hospital volume (0.8% in quartile I vs. 0.2% in quartile IV; p < 0.001). Higher volume independently predicted lower risk of obstruction (OR 0.31, 95% CI 0.16–0.58; p < 0.001) and Clavien-Dindo ≥ III complications (OR 0.71, 95% CI 0.51–0.99; p = 0.044). No significant associations between volume and outcomes were observed for SG or OAGB. Conclusion: Higher hospital volume was associated with fewer severe complications following RYGB, although complication rates remained low across all volume quartiles. Outcomes for SG and OAGB were consistently favourable across all volume quartiles, indicating a lesser influence of hospital volume. These findings support continued evaluation of minimum volume standards within bariatric accreditation frameworks.
- 22 September 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (10) , 5027-5036
Open AccessThe Impact of Hospital Volume on Bariatric Surgery Safety: A Population-Based Study using Data from the National Bariatric Surgery Registry of the United Kingdom
Background: Hospital procedural volume is recognised as an important determinant of outcomes in complex surgery. However, the volume–outcome relationship in bariatric surgery remains incompletely defined. This study examined the association between hospital procedural volume and major complications in primary metabolic bariatric surgery using the United Kingdom (UK) National Bariatric Surgery Registry (NBSR). Methods: Prospectively collected NBSR data from 2014 to 2023 were analysed. Adults undergoing RYGB, SG, or OAGB were included. Hospitals were stratified into quartiles using a four-year moving average of annual procedural volume. Primary outcomes were major postoperative complications, including gastrojejunal obstruction, bleeding, and Clavien-Dindo grade ≥ III events. Multivariable logistic regression assessed associations between hospital volume and outcomes. Results: A total of 54,195 patients were included (RYGB: 23,139; SG: 25,300; OAGB: 4,744). Complication rates were low overall. For RYGB, obstruction rates declined with increasing hospital volume (0.8% in quartile I vs. 0.2% in quartile IV; p < 0.001). Higher volume independently predicted lower risk of obstruction (OR 0.31, 95% CI 0.16–0.58; p < 0.001) and Clavien-Dindo ≥ III complications (OR 0.71, 95% CI 0.51–0.99; p = 0.044). No significant associations between volume and outcomes were observed for SG or OAGB. Conclusion: Higher hospital volume was associated with fewer severe complications following RYGB, although complication rates remained low across all volume quartiles. Outcomes for SG and OAGB were consistently favourable across all volume quartiles, indicating a lesser influence of hospital volume. These findings support continued evaluation of minimum volume standards within bariatric accreditation frameworks.
- 27 June 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (9) , 111974
The impact of Body Mass Index on Esophagectomy: perioperative and oncological outcomes
- 27 June 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (9) , 111974
The impact of Body Mass Index on Esophagectomy: perioperative and oncological outcomes
- Open Access
- 13 October 2025
- Published by Frontiers Media SA in Frontiers in Transplantation
- Vol. 4, 1689018
Comparative systematic review and meta-analysis of pregnancy outcomes after kidney transplantation
Introduction: Advancements in transplant medicine have increased the incidence of pregnancy among kidney transplant recipients. These pregnancies, however, carry elevated maternal and neonatal risks, warranting comprehensive outcome evaluation.Materials and methods: To compare key maternal and neonatal outcomes in pregnancies following kidney transplantation with those in healthy pregnancies. A systematic search of MEDLINE, Embase, and PubMed was conducted up until December 2024. Comparative prospective and retrospective observational studies reporting maternal or neonatal outcomes in pregnancies among kidney transplant recipients and healthy controls. Risk of Bias in Non-Randomized Studies of Interventions (ROBINS-I) was used for quality assessment. Random-effects meta-analyses were conducted to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs) and heterogeneity (I2). Sensitivity analysis explored the impact of study design and bias.Results: Eight studies encompassing 893 pregnancies post-kidney transplantation were included. Relative to healthy pregnancies, kidney-transplant recipients showed markedly higher odds of pre-eclampsia (OR: 10.17, 95% CI: 4.25–24.35; I2 = 86%), gestational hypertension (OR: 7.40, 95% CI: 2.20–24.86; I2 = 84%) and preterm birth (OR: 13.65, 95% CI: 4.79–38.92; I2 = 96%). Caesarean delivery (OR: 3.95, 95% CI: 1.67–9.31; I2 = 93%) and fetal mortality (OR: 4.84, 95% CI: 1.33–17.57; I2 = 79%) were also higher, whereas gestational diabetes did not differ (OR: 1.06, 95% CI: 0.67–1.67; I2 = 0%). Sensitivity analyses confirmed the elevated risks of pre-eclampsia and preterm birth, whereas the associations with caesarean section and fetal mortality did not remain statistically significant after adjustment for study quality.Conclusions: Pregnancies following kidney transplantation are associated with significantly increased maternal and neonatal risks. These findings underscore the need for specialized antenatal care and further large-scale prospective studies to optimize outcomes and inform clinical guidelines.
- 13 October 2025
- Published by Frontiers Media SA in Frontiers in Transplantation
- Vol. 4, 1689018
Open AccessComparative systematic review and meta-analysis of pregnancy outcomes after kidney transplantation
Introduction: Advancements in transplant medicine have increased the incidence of pregnancy among kidney transplant recipients. These pregnancies, however, carry elevated maternal and neonatal risks, warranting comprehensive outcome evaluation.Materials and methods: To compare key maternal and neonatal outcomes in pregnancies following kidney transplantation with those in healthy pregnancies. A systematic search of MEDLINE, Embase, and PubMed was conducted up until December 2024. Comparative prospective and retrospective observational studies reporting maternal or neonatal outcomes in pregnancies among kidney transplant recipients and healthy controls. Risk of Bias in Non-Randomized Studies of Interventions (ROBINS-I) was used for quality assessment. Random-effects meta-analyses were conducted to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs) and heterogeneity (I2). Sensitivity analysis explored the impact of study design and bias.Results: Eight studies encompassing 893 pregnancies post-kidney transplantation were included. Relative to healthy pregnancies, kidney-transplant recipients showed markedly higher odds of pre-eclampsia (OR: 10.17, 95% CI: 4.25–24.35; I2 = 86%), gestational hypertension (OR: 7.40, 95% CI: 2.20–24.86; I2 = 84%) and preterm birth (OR: 13.65, 95% CI: 4.79–38.92; I2 = 96%). Caesarean delivery (OR: 3.95, 95% CI: 1.67–9.31; I2 = 93%) and fetal mortality (OR: 4.84, 95% CI: 1.33–17.57; I2 = 79%) were also higher, whereas gestational diabetes did not differ (OR: 1.06, 95% CI: 0.67–1.67; I2 = 0%). Sensitivity analyses confirmed the elevated risks of pre-eclampsia and preterm birth, whereas the associations with caesarean section and fetal mortality did not remain statistically significant after adjustment for study quality.Conclusions: Pregnancies following kidney transplantation are associated with significantly increased maternal and neonatal risks. These findings underscore the need for specialized antenatal care and further large-scale prospective studies to optimize outcomes and inform clinical guidelines.
- Open Access
Torsion of Tubo-Ovarian Complex during Pregnancy: A Case Report
Introduction: Adnexal torsion is characterised by the rotation of the ovary and, occasionally, the fallopian tube around their supporting ligaments by more than 45 degrees. It predominantly occurs during the first and second trimesters of pregnancy, with an incidence of up to 0.1% in the third trimester. Dermoid and functional ovarian cysts, most commonly associated with benign serous cystadenomas, are frequently identified among the torted adnexal masses. Case Presentation: We report the case of a 32-year-old primigravida with a known ovarian cyst diagnosed in the first trimester, which was managed conservatively throughout the pregnancy. At 36 weeks of gestation, she presented with abdominal pain and was subsequently managed with an emergency caesarean section at 37 weeks due to the development of an acute surgical abdomen. During the procedure, a torted left tubo-ovarian complex was excised, with partial preservation of the healthy-appearing ovarian tissue. Histopathological examination identified the mass as a benign serous cystadenoma. Conclusions: Ovarian torsion during pregnancy poses a significant diagnostic challenge. The decision between conservative management and surgical intervention is primarily guided by a high index of suspicion for torsion.
Open AccessTorsion of Tubo-Ovarian Complex during Pregnancy: A Case Report
Introduction: Adnexal torsion is characterised by the rotation of the ovary and, occasionally, the fallopian tube around their supporting ligaments by more than 45 degrees. It predominantly occurs during the first and second trimesters of pregnancy, with an incidence of up to 0.1% in the third trimester. Dermoid and functional ovarian cysts, most commonly associated with benign serous cystadenomas, are frequently identified among the torted adnexal masses. Case Presentation: We report the case of a 32-year-old primigravida with a known ovarian cyst diagnosed in the first trimester, which was managed conservatively throughout the pregnancy. At 36 weeks of gestation, she presented with abdominal pain and was subsequently managed with an emergency caesarean section at 37 weeks due to the development of an acute surgical abdomen. During the procedure, a torted left tubo-ovarian complex was excised, with partial preservation of the healthy-appearing ovarian tissue. Histopathological examination identified the mass as a benign serous cystadenoma. Conclusions: Ovarian torsion during pregnancy poses a significant diagnostic challenge. The decision between conservative management and surgical intervention is primarily guided by a high index of suspicion for torsion.